EXAS Exact Sciences 8-K2021Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
5 Jan 21
Files
SEC
- 8-K Current report
- 2.1 Plan of acquisition, reorganization, arrangement, liquidation or succession
- 2.2 Plan of acquisition, reorganization, arrangement, liquidation or succession
- 99.1 Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
- Download Excel data file
- View Excel data file
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
EXAS 8-K Filings
- 15 Jan 21 Departure of Directors or Certain Officers
- 11 Jan 21 Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
- 5 Jan 21 Other Events
- 5 Jan 21 Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
- 27 Nov 20 Other Events
- 30 Oct 20 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 27 Oct 20 Exact Sciences Announces Entry into Agreements to Sell $870 million of Common Stock in Registered Direct Offering
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…